was the best predictor for either the atherogenic index or triglycerides among these fat components. Background. Disturbances of lipid and carbohydrate metabolism may be associated with the distribution of Conclusions. These data indicate that haemodialysis patients exhibited a visceral fat accumulation irrespectabdominal adiposity. However, little is known about the alteration of abdominal adiposity and its associ-ive of BMI, and this shift of abdominal adiposity might be associated with disturbance of the serum lipid ation with the serum lipid profile in haemodialysis patients.
position. The electrodes were placed at the upper extremity abnormalities are likely to be associated with the without an arteriovenous fistula and at the lower extremity.
accumulation of visceral rather than subcutaneous
The formulae for calculating the body fat mass were modified abdominal adipose tissue in both obese and normalfrom those that have been validated to correlate with measweight subjects [12, 13] . The development of cardiovasurements by dual-energy X-ray absorptiometry on HD cular disease is also irrespective of body weight in patients [16, 17] : patients with the visceral fat syndrome [13] .
Males: body fat mass (kg)=BW−0.55 (HT2/R)− 16.69 While the metabolic abnormality characteristic of HD patients resemble those associated with these syn-Females: body fat mass (kg)=BW−0.55(HT2/R)−11.49. dromes, there have been few reports concerning body Where BW is the body weight (kg), HT is the height (cm) fat distribution and its significance for metabolic disand R is the impedance (V).
turbances in HD patients. Lee et al. [14] recently
The abdominal fat distribution was determined using CT. demonstrated that abdominal adiposity was not higher The X-ray film was traced by a scanner connected to a in HD patients than in control subjects, and abdominal personal computer. The subcutaneous fat area (SFA) and adiposity might not play an essential role for dyslipida-the visceral fat area ( VFA) were measured using the publicemia and insulin resistance in leaner HD patients. domain program, NIH-image (written by Wayne Rasband However, they might have underrated the role of fat at the US National Institute of Health), at a level between distribution in lipid metabolism because they did not the third and fourth lumbar vertebrae. The intra-abdominal distinguish between intra-abdominal fat accumulation fat mass, having the same density as the subcutaneous fat layer, is defined as the visceral fat.
and subcutaneous abdominal fat accumulation. Fernströ m et al. [15] reported that intra-abdominal fat increased during a 7.2 month follow-up investigation Analytical procedures in patients undergoing continuous ambulatory peritoneal dialysis (CAPD). Those patients, however, received Serum triglycerides, total cholesterol and glucose were a carbohydrate overload through the peritoneal dialys-measured using standard laboratory techniques with an ate and, thus, might have experienced different meta-automatic analyser. Haemoglobin A1c was determined using the latex fixation method, while HDL cholesterol was bolic consequences from those of HD patients. In this measured by the precipitation method using magnesium study, we examined the distribution of abdominal fat phosphotungstate. The plasma insulin was assayed using a using X-ray computed tomography (CT ) and investi- 
Subjects and methods
model was used to calculate the protein catabolic rate (PCR) and the delivered dose of dialysis ( Kt/V urea ) as described previously [18] .
Subjects
Ninety-two patients (57 males and 35 females) undergoing Statistical analysis HD due to various causes at Iwata City Hospital, and 80 control subjects (41 males and 39 females) with normal renal Each value is presented as the mean±SEM and differences function participated in this study. Patients with diabetic between groups, except for triglyceride values, were analysed nephropathy, patients treated with insulin or oral hypoglyca-using the Student's t-test. Comparison of triglyceride values emic agents, and those who had been undergoing HD for between the two groups was performed using the less than 1 year were excluded from the study. None of the Mann-Whitney test because it was not normally distributed. patients was taking lipid-modifying medications, cortico-Simple-and multiple regression analyses were applied to steroids, anabolic steroids, testosterone, oestrogen or proges-examine the relationship between body fat mass, SFA or terone. The HD patients were maintained on a regular HD VFA and various parameters. P-values <0.05 were considprescription three times a week for 4-5 h, using hollow-fibre ered statistically significant. All statistical calculations were dialysers with a bicarbonate-buffered dialysate ( Kindaly performed with GB-STAT software (Dynamic Microsystems, AF-3P, Fuso, Osaka, Japan; or AK-SOLITA, Shimizu, Silver Spring, MD, USA). Shizuoka, Japan). The blood flow rate was in the range of 150-250 ml/min with a dialysate flow rate of 500 ml/min.
Blood samples for biochemical analysis were drawn during
Results
fasting. The serum or plasma was immediately transferred into plastic tubes and stored at −82°C until analysed. Body weight was measured before and after each dialysis, the post-The clinical profiles of the HD group and the agedialysis body weight served as the dry weight. Body mass matched control group are summarized in Table 1 . index (BMI ) was calculated from the formula: post-dialysis Mean BMI and total body fat mass measured using a dry weight/height2.
bioelectrical impedance analysis were significantly lower in the HD patients than in the control subjects.
Measurement of the body fat mass and the abdominal
Mean blood pressure, triglycerides, the AI and insulin fat distribution were significantly higher, while total cholesterol, HDL cholesterol and albumin were significantly lower in the
The body fat mass was measured with a BIA-101 bioelectrical impedance analyser (RJL, Clinton, MI, USA) in the supine HD patients than in the control subjects. The mean SFA in the control subjects was signific-with BMI for both the control subjects and the HD patients. At any BMI value, VFA for the HD patients antly higher than that in the HD patients (Figure 1 ), whereas the mean VFA was not statistically different was higher than that for the control subjects.
Since the pattern of body fat distribution was between the control subjects and the HD patients. Since there was a significant difference in BMI and reported to be somewhat different in males and females, we analysed the data for males and females separately. total body fat mass between the control subjects and the HD patients, SFA and VFA were standardized by The results showed that the relationship between fat distribution and lipid profile for the controls and the BMI in both groups. SFA/BMI for the control subjects was significantly higher than that for the HD patients HD patients was similar for both the males and the females. (Figure 1 ). In contrast, VFA/BMI for the control subjects was significantly lower than that for the HD The respective relationships of BMI, body fat mass, SFA or VFA with the various clinical variables for the patients. The HD patients had a significantly higher V/S ratio, an index of intra-abdominal fat accumula-HD patients are shown in Table 2 . The data indicate that the AI and serum triglyceride level seem to have tion [19] , than the control subjects (Figure 2) . The correlation between BMI and SFA or VFA for both a close correlation with these fat-related parameters.
A multiple regression analysis was thus applied to the control subjects and the HD patients is given in Figure 3 . SFA and VFA were significantly correlated identify which fat parameter had the strongest relation- waist and hips, that upper-body obesity with a high waist-hip ratio was associated with abnormalities in lipid and carbohydrate metabolism. A subsequent epidemiological report showed that the abdominal fat accumulation increased the incidence of cardiovascular disease and death, and that the waist-hip ratio was a better index of complication to obesity than BMI or the subcutaneous fat thickness [23] . However, this classification for the regional distribution of obesity, the waist-hip ratio, is based on the distribution of subcutaneous fat, and the contribution of such intra-abdominal fat as omental and mesenteric Fig. 2 . Comparison of VFA/SFA between the control subjects and adipose tissues was not considered. Borkan et al. [24] haemodialysis patients. Abbreviations: SFA, subcutaneous fat area; VFA, visceral fat area. Data are presented as the mean±SEM.
have developed a method for analysing abdominal fat distribution using CT, and could classify abdominal fat into subcutaneous and intra-abdominal fat masses. ship with the AI and serum triglycerides ( Table 3) .
Visceral obesity, rather than subcutaneous obesity, has VFA was found to be the best respective predictor for been reported to be closely correlated with such AI and triglycerides among the parameters analysed. metabolic disorders as glucose intolerance, hyperinsulinaemia, hyperlipidaemia and hypertension [12, 13, 19, 25, 26 ] . The combination of such metabolic Discussion disorders, called insulin resitance-dyslipidaemic syndrome, is associated with an increased risk of cardioThis study has demonstrated that intra-abdominal vascular disease [25] . adiposity was significantly higher in the HD patients
The current study has demonstrated using a simple than in the control subjects of comparable BMI, while regression analysis that serum lipid levels were associthe mean subcutaneous abdominal adiposity was signiated with BMI, body fat mass, SFA and VFA. ficantly lower in the HD patients than in the control However, the multiple regression analysis revealed that subjects. Consequently, the visceral fat/subcutaneous the VFA measured by CT was the best predictor of fat ratio in the abdomen was significantly higher in AI and serum triglyceride level. These data principally the HD patients than in the control subjects. We also agree with those of previous studies evaluating the role found that the visceral fat accumulation was associated of visceral obesity in lipid and carbohydrate metabolwith the serum lipid abnormalities in the HD patients.
ism in a general population. Obesity has been recognized as a serious risk factor
The accumulation of intra-abdominal adipose tissue for mortality and morbidity for cardiovascular diseases with higher lipolytic activity [27] is associated with the in the general population [20] . We have also reported excess release of free fatty acid into the portal vein. that being overweight is a risk factor for mortality and Increased delivery of free fatty acid in the portal vein morbidity over 10 years in HD patients [21] . Recent may result in reduced hepatic insulin clearance and studies have demonstrated that cardiovascular disease increased hepatic glucose production [28] . Together and its related mortality might be affected by not only with these mechanisms, the peripheral insulin resistance the total amount of body fat, but also by the regional exacerbates hyperinsulinaemia in patients with visceral distribution of body fat. Kissebah et al. [22] have demonstrated, by measuring circumferences of the obesity [25] . Furthermore, abdominal adiposity is Fig. 3 . Relationships of SFA or VFA with BMI for the control subjects and haemodialysis patients. SFA was significantly correlated with BMI in both the control subjects (r=0.77, P<0.001) and haemodialysis patients (r=0.73, P<0.001). VFA was also significantly correlated with BMI in both the control subjects (r=0.60, P<0.001) and haemodialysis patients (r=0.69, P<0.001). VFA in the haemodialysis patients was significantly higher than in the control subjects for any BMI value. Controls (#, dashed line); haemodialysis patients ($, solid line). Abbreviations: SFA, subcutaneous fat area; VFA, visceral fat area; BMI, body mass index. in a non-uraemic population. Further study will be required to clarify the mechanism for the increase in the intra-abdominal adiposity in HD patients. The associated with overproduction of VLDL which might lead to hypertriglyceridaemia and hypercholesterolae-direct effect of renal failure or the HD procedure on fat distribution might have to be considered. mia [26 ] . Després et al. [28] also demonstrated that a high level of visceral adipose tissue was associated with
In conclusion, the HD patients exhibited an excess accumulation of intra-abdominal adipose tissue relatlow HDL cholesterol/LDL cholesterol ratio and low HDL 2 fraction of HDL cholesterol. ive to the healthy subjects, although the mean subcutaneous abdominal adipose tissue was lower in the HD The metabolic alterations accompanying renal failure may also be responsible for dyslipidaemia and patients than in the control subjects. This shift in abdominal fat distribution might be associated, in part, hyperinsulinaemia independent of the fat distribution in HD patients. HD patients have been reported to with metabolic disturbances affecting lipids, including the increased AI index and serum triglyceride level. have a decreased concentration of hepatic triglyceride lipase [29] and an increased level of the lipoprotein The treatment of visceral fat accumulation is considered to be important for preventing the progression of lipase inhibitor [30] . These abnormalities would result in the increase of VLDL with decreasing LDL. Lee atherosclerotic vascular diseases in HD patients. et al. [14] suggested that the uraemic condition affected waist-hip ratio and plasma lipoproteins in non-obese
